CJC-1295: A growth hormone-releasing peptide, CJC-1295 stimulates the release of growth hormones from the pituitary gland
Exogenous testosterone also exerts negative feedback on the hypothalamic-pituitary-gonadal axis: it suppresses pituitary release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to reduced endogenous testosterone production and diminished spermatogenesis
However, insufficient evidence exists to justify the discontinuation of GLP-1 RAs before the procedure, and the ideal cessation timing for these agents remains indeterminate
Practically, that means: Start extremely low sometimes at one-tenth or one-fifth of the usual initial dose
Specifically, we are finalizing our proposed definitions for three new data elements, the median allowed amount, the tenth (10th) percentile allowed amount, and the ninetieth (90th) percentile allowed amount with modification to revise the phrase, no longer than the 12 months to state, no less than 12 months and no longer than 15 months. Final Action: After consideration of public comments, we are finalizing the proposed definitions of median allowed amount, tenth (10th) percentile allowed amount, and ninetieth (90th) percentile allowed amount with modification to reflect a lookback period of no less than 12 months and no longer than 15 months prior to posting the MRF
